OBJECTIVE: Since the unexpected results from the Women's Health Initiative, the possible protective role of estrogen in preventing heart disease in perimenopausal and postmenopausal women is uncertain. This study examined atherosclerotic lesion development in ovariectomized versus follicle-depleted ovary-intact cholesterol-fed female low-density lipoprotein (LDL) receptor-deficient mice. METHODS AND RESULTS: We studied lesion development in LDL receptor-deficient mice that were ovariectomized or follicle depleted with 4-vinylcyclohexene diepoxide (VCD) to induce ovarian failure, then treated +/- exogenous 17beta-estradiol via pellet implant. At 120 days after start of cholesterol feeding, the extent of lesion in aorta and innominate artery was determined. Lesion area in both locations was similar in vehicle control, VCD-treated, and ovariectomized mice. Replacement with 17beta-estradiol caused lesion reduction (P<0.05) in both arterial locations, but it was most efficacious in suppressing innominate lesion area in VCD-treated mice (12.9+/-5.2%) compared with ovariectomized mice (40.0+/-6.04%). CONCLUSIONS: Endocrine status associated with the follicle-depleted ovary influences exogenous estradiol effects during the development of atherosclerotic lesions and, in particular, inhibits lesion progression in the innominate artery.
OBJECTIVE: Since the unexpected results from the Women's Health Initiative, the possible protective role of estrogen in preventing heart disease in perimenopausal and postmenopausal women is uncertain. This study examined atherosclerotic lesion development in ovariectomized versus follicle-depleted ovary-intact cholesterol-fed female low-density lipoprotein (LDL) receptor-deficient mice. METHODS AND RESULTS: We studied lesion development in LDL receptor-deficient mice that were ovariectomized or follicle depleted with 4-vinylcyclohexene diepoxide (VCD) to induce ovarian failure, then treated +/- exogenous 17beta-estradiol via pellet implant. At 120 days after start of cholesterol feeding, the extent of lesion in aorta and innominate artery was determined. Lesion area in both locations was similar in vehicle control, VCD-treated, and ovariectomized mice. Replacement with 17beta-estradiol caused lesion reduction (P<0.05) in both arterial locations, but it was most efficacious in suppressing innominate lesion area in VCD-treated mice (12.9+/-5.2%) compared with ovariectomized mice (40.0+/-6.04%). CONCLUSIONS: Endocrine status associated with the follicle-depleted ovary influences exogenous estradiol effects during the development of atherosclerotic lesions and, in particular, inhibits lesion progression in the innominate artery.
Authors: Tracey A Van Kempen; Ankita Narayan; Elizabeth M Waters; Jose Marques-Lopes; Costantino Iadecola; Michael J Glass; Virginia M Pickel; Teresa A Milner Journal: J Comp Neurol Date: 2015-12-23 Impact factor: 3.215
Authors: Stephanie V Koebele; Sarah E Mennenga; Ryoko Hiroi; Alicia M Quihuis; Lauren T Hewitt; Mallori L Poisson; Christina George; Loretta P Mayer; Cheryl A Dyer; Leona S Aiken; Laurence M Demers; Catherine Carson; Heather A Bimonte-Nelson Journal: Horm Behav Date: 2016-10-26 Impact factor: 3.587
Authors: Mari S Golub; Stacey L Germann; Mary Mercer; Marcia N Gordon; David G Morgan; Loretta P Mayer; Patricia B Hoyer Journal: Neurobiol Aging Date: 2007-04-23 Impact factor: 4.673
Authors: Brian G Choi; Gemma Vilahur; M Urooj Zafar; Luis Cardoso; Daniel Yadegar; Borja Ibanez; James Tunstead; Juan F Viles-Gonzalez; Mitchell B Schaffler; Valentin Fuster; Juan J Badimon Journal: Atherosclerosis Date: 2008-02-21 Impact factor: 5.162